Revisión sistemática de intervención farmacéutica en pacientes ambulatorios con diabetes mellitus tipo II

Abstract

Introduction: Diabetes mellitus type II is a chronic disease caused by the alteration of cells of the pancreas which produces elevated glucose in the blood, poor control of it triggers a decrease in the quality of life of the patient, in addition to multiple complications. vascular in the future. That is why there is great concern in health systems, since it has been statistically reported that it is one of the main causes of morbidity and mortality globally. It has been shown that the intervention of pharmacotherapeutic therapies, together with the modification of eating habits and long-term physical activity, are the best options for glycemic control. Objective: To determine the importance of Pharmaceutical Intervention in outpatients with type II diabetes mellitus, by reviewing scientific documents to improve their quality of life. Methodology: A qualitative research was used, and a descriptive methodology based on the analysis of scientific literature in journal repositories such as PubMed, Scielo, Redalyc, among others. Conclusion: Pharmaceutical intervention plays an important role in the control of chronic diseases, including type II diabetes, studies show that the participation of pharmaceutical professionals in the educational part regarding the correct administration of the drug produces a positive impact in outpatients. , achieving a significant reduction in HbA1c and fasting glucose.